Insights - Sloanmaccallum Cancer Care

Skip to content

Home
About Us
Services
Insights
Research
Contact Us

Home
About Us
Services
Insights
Research
Contact Us

Insights

High PSA level with enlarged prostate, prostate MRI and urinary symptoms

Prostate Cancer

PSA 8.4 with a 120 mL prostate: does this mean prostate cancer? | Dr Dilanka De Silva

October 1, 2026

Hormone treatment after prostate cancer surgery illustrated with prostate anatomy and hormone therapy medications.

Prostate Cancer

Do you need hormone treatment after prostate cancer surgery? | Dr Dilanka De Silva

October 1, 2026

Peritoneal mesothelioma treatment illustration showing abdominal cancer, cytoreductive surgery and HIPEC

Uncategorized

If you had to have a mesothelioma, is peritoneal mesothelioma the one you would choose? | Dr Dilanka De Silva

September 25, 2026

HIPEC for colon cancer illustration showing cytoreductive surgery and heated chemotherapy in the abdomen

Colon cancer

HIPEC for stage 4 colon cancer: could this major operation actually help me? | Dr Dilanka De Silva

September 10, 2026

ALK positive lung cancer illustration showing lungs, DNA and targeted therapy tablets

Lung Cancer

If you had to have stage IV lung cancer, is ALK-positive the best type to have? | Dr Dilanka De Silva

September 8, 2026

PET-negative lung nodule being reviewed on CT and PET imaging

Lung Cancer

The lung nodules were PET-negative—but they were still growing | Dr Dilanka De Silva

September 6, 2026

Lung cancer genomic testing illustration showing lungs, a tumour and a DNA helix

Lung Cancer

What if your lung cancer has a treatment hidden in its DNA? | Dr Dilanka De Silva

September 3, 2026

PET scans: Dr Dilanka explains FDG PET, PSMA PET, fasting, diabetes and why different cancers may require different radioactive tracers.

Uncategorized

Not all PET scans are the same: why the tracer matters | Dr Dilanka De Silva

September 3, 2026

Stage IV kidney cancer illustration showing a kidney tumour within the urinary system

Uncategorized

Stage IV kidney cancer: should you have the kidney removed? | Dr Dilanka De Silva

August 30, 2026

Prostate cancer recurrence illustration showing the prostate with molecular and genetic elements representing changing cancer biology

Prostate Cancer

Prostate cancer has come back: what do castration-sensitive and castration-resistant really mean? | Dr Dilanka De Silva

August 28, 2026

High PSA illustration showing PSA blood testing, prostate MRI, pathology and advanced prostate cancer imaging

Prostate Cancer

High PSA? Don’t panic. Here’s exactly what happens next | Dr Dilanka De Silva

August 27, 2026

Metastatic prostate cancer illustration showing prostate cancer and bone metastases in the pelvis

Prostate Cancer

Has prostate cancer treatment moved faster than clinical trials? What PEACE-3 taught me | Dr Dilanka De Silva

August 24, 2026

Brain cancer Melbourne illustration showing a brain tumour and molecular tumour cells

Uncategorized

Why brain cancer is different from almost every other cancer | Dr Dilanka De Silva

August 22, 2026

Elevated PSA Melbourne prostate assessment showing prostate anatomy, PSA blood testing and prostate MRI.

Prostate Cancer

My PSA increased from 11 to 13. Should I be worried? | Dr Dilanka De Silva

August 14, 2026

Breast cancer screening medical illustration showing mammography, ultrasound, breast MRI and genetic information used to guide breast cancer screening.

Breast cancer

Mammogram, ultrasound or breast MRI: Which breast scan is right for you? | Dr Dilanka De Silva

August 10, 2026

Medical illustration of breast cancer cells and a pink awareness ribbon representing triple-positive HER2-positive breast cancer.

Breast cancer

Triple-positive breast cancer: What happens next? | Dr Dilanka De Silva

August 8, 2026

Illustration of T1 bladder cancer in Melbourne showing a tumour confined to the bladder lining and supporting tissue.

Bladder Cancer

Early bladder cancer Melbourne: recurrence is not the same as progression | Dr Dilanka De Silva

August 6, 2026

Illustration of treatment planning for metastatic prostate cancer after hormone tablets, showing prostate cancer, a patient at a treatment crossroads, and options including genetic testing, chemotherapy, PSMA-targeted therapy and bone care.

Prostate Cancer

I have already tried one hormone tablet for metastatic prostate cancer. Can I simply switch to another? | Dr Dilanka De Silva

August 6, 2026

Multidisciplinary team planning high-risk prostate cancer treatment with imaging, pathology and tumour biology

Prostate Cancer

Medical oncology and the changing landscape of high-risk prostate cancer | Dr Dilanka De Silva

August 1, 2026

Prostate Cancer

Can treatment around prostate cancer surgery reduce the risk of recurrence? | Dr Dilanka De Silva

July 31, 2026

Prostate Cancer

My MRI was normal, but my PSA is still high. Should I have another MRI? | Dr Dilanka De Silva

July 30, 2026

Prostate Cancer

My PSA is rising after prostate cancer treatment, but my PSMA PET scan is negative. Should I start hormone therapy? | Dr Dilanka De Silva

July 28, 2026

Colon cancer

My colon cancer has stopped responding to chemotherapy. Are there any new treatments available? | Dr Dilanka De Silva

July 26, 2026

Colon cancer

Why did my friend with stage IV bowel cancer receive different treatment than me? | Dr Dilanka De Silva

July 22, 2026

Colon cancer

My Colon Cancer Was Completely Removed. Do I Still Need Chemotherapy? | Dr Dilanka De Silva

July 22, 2026

Colon cancer

Stage III colon cancer: what else can I do to reduce the chance of my cancer coming back? | Dr Dilanka De Silva

July 20, 2026

Breast cancer

BRCA1 genetic testing in Melbourne: Can it change triple-negative breast cancer treatment? | Dr Dilanka De Silva

July 18, 2026

Breast cancer

I was taught that liver metastases often meant chemotherapy. The evidence changed my mind | Dr Dilanka De Silva

July 15, 2026

Breast cancer

Can denosumab reduce the risk of breast cancer coming back? What every high-risk breast cancer patient should know | Dr Dilanka De Silva

July 14, 2026

Breast cancer

Is there a “best” type of breast cancer? Why small HER2-positive breast cancer can have an excellent prognosis | Dr Dilanka De Silva

July 13, 2026

Prostate Cancer

A new prostate cancer study that may change treatment in the future | Dr Dilanka De Silva

July 8, 2026

Prostate Cancer

AMPLITUDE: Should treatment be intensified from the beginning for BRCA2-positive metastatic prostate cancer? | Dr Dilanka De Silva

July 7, 2026

Prostate Cancer

Why two men with the same metastatic prostate cancer can have very different outcomes? | Dr Dilanka De Silva

July 6, 2026

Prostate Cancer

Your CT scan was normal. Why did the PSMA PET find cancer? | Dr Dilanka De Silva

July 5, 2026

Prostate Cancer

Prostate cancer with lymph node involvement: why some men may benefit from more treatment at the beginning | Dr Dilanka De Silva

July 4, 2026

Prostate Cancer

Prostate cancer treatment in Melbourne: the 3 biggest changes over the last decade | Dr Dilanka De Silva

July 4, 2026

Colon cancer

Is One Immunotherapy Drug Enough for MSI-High Metastatic Colon Cancer, or Is Two Better? | Dr Dilanka De Silva

July 1, 2026

Colon cancer

Lynch Syndrome and Colon Cancer: Could Immunotherapy Change Everything? | Dr Dilanka De Silva

June 28, 2026

Colon cancer

You’ve been diagnosed with colon cancer or rectal cancer. Will immunotherapy work for me? | Dr Dilanka De Silva

June 28, 2026

Colon cancer

ATOMIC Study: Could Immunotherapy Reduce Colon Cancer From Returning? | Dr Dilanka De Silva

June 26, 2026

Colon cancer

Could a simple aspirin tablet reduce the risk of bowel cancer returning? Lessons from the ALASCCA trial | Dr Dilanka De Silva

June 25, 2026

Colon cancer

What else can I do after chemotherapy for bowel cancer? A simple tablet may now reduce the risk of recurrence | Dr Dilanka De Silva

June 24, 2026

Colon cancer

Can a blood test help me avoid chemotherapy after colon cancer surgery? | Dr Dilanka De Silva

June 23, 2026

Colon cancer

Colon cancer after chemotherapy: can exercise really reduce the chance of the cancer returning? | Dr Dilanka De Silva

June 21, 2026

Lung Cancer

EGFR-mutated lung cancer after surgery: why tablets after treatment still matter (ADAURA trial): lung cancer treatment in Melbourne Australia | Dr Dilanka De Silva

April 28, 2026

Lung Cancer

Entrectinib for ROS1-positive lung cancer: why the right test at the beginning can change everything | Dr Dilanka De Silva

April 22, 2026

Lung Cancer

HER2-positive lung cancer: why the test result alone is not enough | Dr Dilanka De Silva

April 21, 2026

Lung Cancer

HER2 testing in lung cancer: why it is not the same as other cancers | Dr Dilanka De Silva

April 18, 2026

Lung Cancer

Why molecular testing at the beginning can change the entire course of lung cancer treatment | Dr Dilanka De Silva

April 4, 2026

Lung Cancer

EGFR-Mutated Lung Cancer: Beyond the Diagnosis to Precision Management | Dr Dilanka De Silva

April 3, 2026

General contact

Phone: 1300 709 456
Phone enquiries are reserved for urgent matters or referring clinicians.
Email: [email protected]
We aim to respond to patient enquiries within 24 hours (business days).

Referrals

All referrals are seen within 2 weeks
Australian referrals: HealthLink strongly preferred
HealthLink EDI: desilvad
If HealthLink is not available, referrals may be sent to: [email protected]

Facebook Youtube

General contact

Epworth Freemasons

Suite 8.2, 124 Grey Steet,
East Melbourne
Victoria 3002
Australia.

Public appointments
Peter MacCallum Cancer Centre
Royal Melbourne Hospital

Links

Home
About
Service
Contact Us

International Booking

Contact Us

Copyright © 2026 Sloanmaccallum Cancer Care
Privacy Policy

Scroll to Top